Nakai Y, Tanaka N, Asakawa I, Miyake M, et al. Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after (125)I-brachytherapy for prostate cancer: An open-labeled, randomized, non-placebo-controlled study. Urology 2021 Dec 29. pii: S0090-4295(21)01183.
PMID: 34973240